<DOC>
	<DOCNO>NCT01655394</DOCNO>
	<brief_summary>IVIg exert variety different immunomodulatory effect several mechanism action propose IVIg . In study role IVIg short term nerve conduction patient immune-mediated neuropathy explore .</brief_summary>
	<brief_title>Change Nerve Conduction Properties IVIg Dependent Neuropathies</brief_title>
	<detailed_description>IVIg exert variety different immunomodulatory effect several mechanism action propose IVIg . In study role IVIg short term nerve conduction patient immune-mediated neuropathy explore</detailed_description>
	<mesh_term>Guillain-Barre Syndrome</mesh_term>
	<criteria>immune neuropathy age 18 IVIg treatment exclusion : IVIg treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>